Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme. Velorum Therapeutics is a Y Combinator company (Winter 2024). YC-listed status: Active.
- Website
- velorumtx.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Velorum Therapeutics — Drug pipeline targeting heme biology to treat porphyrias, cancer, and tissue injury. · Other
Links
- Y Combinator profileycombinator